These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3831944)

  • 41. [To the Editors: Comment on the study by Kullmann and Misset "Benefits of mammographic breast cancer screening"].
    Kovács A; Budai A; Döbrössy L; Péntek Z; Ormándi K; Forrai G
    Orv Hetil; 2010 Dec; 151(49):2031-2, discussion 2033-4.. PubMed ID: 21106484
    [No Abstract]   [Full Text] [Related]  

  • 42. Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild.
    Page DL; Jensen RA
    JAMA; 1996 Mar; 275(12):948-9. PubMed ID: 8598624
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of Impact of the 2009 USPSTF Guidelines on Rates of Mammography Screening.
    Brown C; Nevola A; Martin BC
    J Womens Health (Larchmt); 2018 Jul; 27(7):875-884. PubMed ID: 29583065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.
    Kopans DB
    Radiol Clin North Am; 2010 Sep; 48(5):843-57. PubMed ID: 20868889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The value of the localization technique of occult breast changes with reference to future screening programs].
    Hess T; Benz J; Juchler A
    Helv Chir Acta; 1992 May; 59(1):263-8. PubMed ID: 1526839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparities in screening mammography. Current status, interventions and implications.
    Peek ME; Han JH
    J Gen Intern Med; 2004 Feb; 19(2):184-94. PubMed ID: 15009798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regarding trends in recall, biopsy, and positive biopsy rates for screening mammography.
    Ellis RL
    Radiology; 2006 Jan; 238(1):375-6; author reply 376. PubMed ID: 16373783
    [No Abstract]   [Full Text] [Related]  

  • 48. Breast cancer screening: recent trends in the use of mammography in Nebraska.
    Rettig B; Nelson N; Faulk R
    Nebr Med J; 1994 May; 79(5):136-8; discussion 139. PubMed ID: 8047188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Current controversy on the effectiveness of mammographic screening for breast cancer in western nations].
    Kuriyama S; Tsuji I
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):158-62. PubMed ID: 14997744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Breast cancer: generalised screening in France from now on].
    Séradour B
    Rev Prat; 2004 Apr; 54(8):830-6. PubMed ID: 15274453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Confusion over mammography screening intensifies.
    Lancet Oncol; 2002 Mar; 3(3):127. PubMed ID: 11902495
    [No Abstract]   [Full Text] [Related]  

  • 52. American College of Radiology guidelines for breast cancer screening.
    Feig SA; D'Orsi CJ; Hendrick RE; Jackson VP; Kopans DB; Monsees B; Sickles EA; Stelling CB; Zinninger M; Wilcox-Buchalla P
    AJR Am J Roentgenol; 1998 Jul; 171(1):29-33. PubMed ID: 9648758
    [No Abstract]   [Full Text] [Related]  

  • 53. Breast cancer screening and other news.
    J Ark Med Soc; 2014 Oct; 111(5):82-3. PubMed ID: 25647973
    [No Abstract]   [Full Text] [Related]  

  • 54. [Mammography as a screening test before age 50].
    Segnan N
    Epidemiol Prev; 1997; 21(2):86-7. PubMed ID: 9378186
    [No Abstract]   [Full Text] [Related]  

  • 55. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The breast cancer screening controversy and the National Institutes of Health Consensus Development Conference on Breast Cancer Screening for Women Ages 40-49.
    Kopans DB
    Radiology; 1999 Jan; 210(1):4-9. PubMed ID: 9885578
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical versus research approach to breast cancer detection with CAD: where are we now?
    Brem RF
    AJR Am J Roentgenol; 2007 Jan; 188(1):234-5. PubMed ID: 17179371
    [No Abstract]   [Full Text] [Related]  

  • 58. Decreased mammography utilization in the United States: why and how can we reverse the trend?
    Wolf AB; Brem RF
    AJR Am J Roentgenol; 2009 Feb; 192(2):400-2. PubMed ID: 19155401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years.
    Feig SA
    Cancer; 1995 May; 75(10):2412-9. PubMed ID: 7736383
    [No Abstract]   [Full Text] [Related]  

  • 60. Breast cancer screening among women from 65 to 74 years of age in 1987-88 and 1991. NCI Breast Cancer Screening Consortium.
    Coleman EA; Feuer EJ
    Ann Intern Med; 1992 Dec; 117(11):961-6. PubMed ID: 1443958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.